Alternatives to currently used antimalarial drugs: in search of a magic bullet
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternatives to currently used antimalarial drugs: in search of a magic bullet
Authors
Keywords
Malaria, Drug development, Medicine for malaria venture, Chemotherapy, Tafenoquine, Fosmidomycin, Novel antimalarial drugs, Artemisinin derivatives
Journal
Infectious Diseases of Poverty
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-04
DOI
10.1186/s40249-016-0196-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Spiroindolone KAE609 Does Not Induce Dormant Ring Stages in Plasmodium falciparum Parasites
- (2016) Marina Chavchich et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
- (2016) Aung Pyae Phyo et al. LANCET INFECTIOUS DISEASES
- Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study
- (2016) Kerryn A Moore et al. LANCET INFECTIOUS DISEASES
- Antimalarial drug resistance in Africa: key lessons for the future
- (2015) Shannon Takala-Harrison et al. Annals of the New York Academy of Sciences
- Open-Label, Single-Dose, Parallel-Group Study in Healthy Volunteers To Determine the Drug-Drug Interaction Potential between KAE609 (Cipargamin) and Piperaquine
- (2015) Daniel S. Stein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Mu Subunit of Plasmodium falciparum Clathrin-Associated Adaptor Protein 2 ModulatesIn VitroParasite Response to Artemisinin and Quinine
- (2015) Gisela Henriques et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study
- (2015) Jana Held et al. LANCET INFECTIOUS DISEASES
- Malaria runs rings round artemisinin
- (2015) Jeremy Burrows NATURE
- A novel multiple-stage antimalarial agent that inhibits protein synthesis
- (2015) Beatriz Baragaña et al. NATURE
- Malaria medicines: a glass half full?
- (2015) Timothy N. C. Wells et al. NATURE REVIEWS DRUG DISCOVERY
- A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
- (2015) Margaret A. Phillips et al. Science Translational Medicine
- Artemisinin-resistant Plasmodium falciparum clinical isolates can infect diverse mosquito vectors of Southeast Asia and Africa
- (2015) Brandyce St. Laurent et al. Nature Communications
- Lysine Acetylation in Sexual Stage Malaria Parasites Is a Target for Antimalarial Small Molecules
- (2014) Katharine Trenholme et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
- (2014) F. Joel Leong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ex VivoActivity of Endoperoxide Antimalarials, Including Artemisone and Arterolane, against Multidrug-Resistant Plasmodium falciparum Isolates from Cambodia
- (2014) Charlotte A. Lanteri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
- (2014) Kelli L. Kuhen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Triple Combination Therapy With Artesunate-Amodiaquine–Methylene Blue for Falciparum Malaria in Children: A Randomized Controlled Trial in Burkina Faso
- (2014) Boubacar Coulibaly et al. JOURNAL OF INFECTIOUS DISEASES
- Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
- (2014) Elizabeth A. Ashley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spiroindolone KAE609 for Falciparum and Vivax Malaria
- (2014) Nicholas J. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance ofPlasmodium
- (2014) María Belén Jiménez-Díaz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New insight-guided approaches to detect, cure, prevent and eliminate malaria
- (2014) Sushil Kumar et al. PROTOPLASMA
- Plasmepsin Inhibitory Activity and Structure-Guided Optimization of a Potent Hydroxyethylamine-Based Antimalarial Hit
- (2014) Kristaps Jaudzems et al. ACS Medicinal Chemistry Letters
- Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum
- (2014) Akhil B. Vaidya et al. Nature Communications
- High prevalence of pfmdr1 N86Y and Y184F mutations inPlasmodium falciparumisolates from Bioko island, Equatorial Guinea
- (2014) Jian Li et al. Pathogens and Global Health
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
- (2014) PLOS MEDICINE
- Recent advances in malaria drug discovery
- (2013) Marco A. Biamonte et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Neurotoxicity Assessment of Artemether in Juvenile Rats
- (2013) David A. Beckman et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Isolation and synthesis of falcitidin, a novel myxobacterial-derived acyltetrapeptide with activity against the malaria target falcipain-2
- (2013) Brinda Somanadhan et al. JOURNAL OF ANTIBIOTICS
- Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential
- (2013) Thomas Antoine et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study
- (2013) Alejandro Llanos-Cuentas et al. LANCET
- Targeting Plasmodium PI(4)K to eliminate malaria
- (2013) Case W. McNamara et al. NATURE
- A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
- (2013) Frédéric Ariey et al. NATURE
- Randomized, Prospective, Three-Arm Study to Confirm the Auditory Safety and Efficacy of Artemether-Lumefantrine in Colombian Patients with Uncomplicated Plasmodium falciparum Malaria
- (2012) Gabriel Carrasquilla et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939
- (2012) Subathdrage D. M. Sumanadasa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeEx VivoActivity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivax
- (2012) Jutta Marfurt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial
- (2012) N. Valecha et al. CLINICAL INFECTIOUS DISEASES
- Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1
- (2012) José M Bueno et al. Future Medicinal Chemistry
- 3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential
- (2012) Yassir Younis et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Effect of Monthly Sulfadoxine-Pyrimethamine, Alone or with Azithromycin, on PCR-Diagnosed Malaria at Delivery: A Randomized Controlled Trial
- (2012) Mari Luntamo et al. PLoS One
- Aminoindoles, a Novel Scaffold with Potent Activity against Plasmodium falciparum
- (2011) Robert H. Barker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ex VivoDrug Susceptibility of Ferroquine against Chloroquine-Resistant Isolates of Plasmodium falciparum and P. vivax
- (2011) Jutta Marfurt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies PotentPlasmodium falciparumDihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
- (2011) Jose M. Coteron et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection
- (2011) Ghyslain Mombo-Ngoma et al. MALARIA JOURNAL
- Plasmodium falciparum Parasites Are Killed by a Transition State Analogue of Purine Nucleoside Phosphorylase in a Primate Animal Model
- (2011) María B. Cassera et al. PLoS One
- A Research Agenda to Underpin Malaria Eradication
- (2011) Pedro L. Alonso et al. PLOS MEDICINE
- A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single Enantiomer (+)-Mefloquine Compared with Racemic Mefloquine in Healthy Persons
- (2010) Robert Tansley et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Identification of a 1,2,4,5-Tetraoxane Antimalarial Drug-Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins
- (2010) Paul M. O'Neill et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Novel Inhibitors ofPlasmodium falciparumDihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model
- (2010) Michael L. Booker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Spiroindolones, a Potent Compound Class for the Treatment of Malaria
- (2010) M. Rottmann et al. SCIENCE
- Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso
- (2010) Mamadou Bountogo et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Origin and Evolution of Sulfadoxine Resistant Plasmodium falciparum
- (2010) Sumiti Vinayak et al. PLoS Pathogens
- Artemisinin Resistance inPlasmodium falciparumMalaria
- (2009) Arjen M. Dondorp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetic and Toxicological Profile of Artemisinin Compounds: An Update
- (2009) Bikash Medhi et al. PHARMACOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- First Assessment in Humans of the Safety, Tolerability, Pharmacokinetics, and Ex Vivo Pharmacodynamic Antimalarial Activity of the New Artemisinin Derivative Artemisone
- (2008) J. Nagelschmitz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria
- (2008) Ronnatrai Ruengweerayut et al. MALARIA JOURNAL
- Safety and Efficacy of Methylene Blue Combined with Artesunate or Amodiaquine for Uncomplicated Falciparum Malaria: A Randomized Controlled Trial from Burkina Faso
- (2008) Augustin Zoungrana et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started